Ames Seed Capital

Ames Seed Capital, LLC is a venture capital firm established in 1987 and based in Ames, Iowa. The firm focuses on investing in startups, early-stage companies, and expansions, primarily within Ames and the surrounding areas of Story City, Nevada, and Huxley. It operates as a collective of private investors dedicated to fostering economic growth and development in central Iowa. By supporting new enterprises and enhancing existing industries, Ames Seed Capital plays a significant role in the local economic landscape.

Mike Upah

Director

6 past transactions

VetMeasure

Seed Round in 2019
VetMeasure, Inc. designs and manufactures a health monitoring device for animals. The company offers MeasureOn, which is a harness that allows veterinarians to monitor an animal’s heart and pulse rates, respiration and body temperature, activity, and ambient temperature and humidity to determine an animal’s condition following surgical procedures or illness. Its product uses Bluetooth technology and web application. The company was founded in 2015 and is based in Ames, Iowa.

Pitchly

Convertible Note in 2019
Pitchly, Inc. is a technology company that offers a cloud-based content services platform designed for merger and acquisition professionals. Founded in 2014 and based in Des Moines, Iowa, Pitchly provides a platform that enables users to create and manage custom databases to efficiently organize and activate intellectual property. The platform allows non-technical users to generate data-rich real-time documents in PowerPoint and Word, significantly reducing the time and errors associated with traditional methods of document creation. By aggregating various digital data sources, such as Excel and Salesforce, into a single, normalized view, Pitchly enhances accessibility and usability of information. The service is particularly beneficial for investment banks, accounting and advisory firms, and law firms, as it streamlines the process of locating and integrating relevant data into professional documents and presentations. Additionally, users can create custom forms to ensure that teams access the most current information available.

automed

Seed Round in 2018
automed Inc designs and manufactures automatic livestock medication systems. It offers automed, an automatic livestock medication systems that automatically calculates, delivers, and record livestock treatments, and help livestock producers manage their operation; and automed adapters that allow user to administer medication through injection, drench, pour-on and intra-nasal automatically, accurately, and efficiently. The company was founded in 2012 and is based in Belconnen, Australia.

FindBoB

Seed Round in 2017
FindBoB is a growth, transition and succession planning tool for financial advisors and insurance agents, utilizing machine learning and elements of gamification for asset protection.

NewLink Genetics

Series C in 2008
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.

NewLink Genetics

Series B in 2007
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.